Condition
Response, Acute Phase
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05889312Recruiting
Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET
NCT06284395RecruitingPrimary
Two Schemes Response in Multiple Myeloma
NCT04838938Completed
Personalized Medicine in Patients With Infective Endocarditis
NCT05642117Completed
Pediatric Telephone Center Board 15
Showing all 4 trials